AMI Pharm's AYP-101 Breakthrough in Nonsurgical Fat Reduction: Phase 2 Results AMI Pharm's injectable drug AYP-101 shows promising results in Phase 2 testing for nonsurgical fat reduction, marking a significant advancement in aesthetics.

AMI Pharm's AYP-101 Breakthrough in Nonsurgical Fat Reduction: Phase 2 Results #South_Korea #Seoul #AMI_Pharm #AYP-101 #Nonsurgical_Solution